Hani Babiker

Senior Associate Consultant, Associate Director · Stony Brook Medicine

Credentials: · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Hematology and Medical Oncology
2003–2006
Internal Medicine
2000–2003
Doctor of Medicine
1996–2000

Research

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2018 · 1,114 citations
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Review · Clinical Cancer Research · 2018 · 289 citations
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis
Systematic review or meta-analysis · The Prostate · 2019 · 111 citations

Mitesh Borad
32 papers
Tanios Bekaii-Saab
18 papers
Daruka Mahadevan
17 papers
Umair Majeed
13 papers
AM
Ali McBride
12 papers
Mohamad Sonbol
12 papers
Nguyen Tran
11 papers
Jason Starr
10 papers
Alejandro Boiles
9 papers · 7 as a fellow
Amit Mahipal
9 papers
Daniel Ahn
9 papers
EE
Emad Elquza
9 papers

Clinical trials

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma
Principal investigator · Terminated · Phase 1
Mayo Clinic
2022–2025
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
Principal investigator · Recruiting · Phase 1, Phase 2
Mayo Clinic
2022–2028
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Principal investigator · Completed · Phase 1
Sirnaomics
2021–2024
E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)
Principal investigator · Terminated · Phase 1
Spirita Oncology, LLC
2018–2021